XDTM13

XDTM13 is a biphenyl amide small-molecule TMPRSS2 inhibitor derived from the lead scaffold Avoralstat (HY-16735), with an IC50 of 3.60 nM. XDTM13 inhibits the autoproteolytic cleavage of TMPRSS2 protein in prostate cancer LNCaP cells and suppresses the migration and invasion ability of LNCaP cells. XDTM13 can be used for research on prostate cancer.

For research use only. We do not sell to patients.

  • Formula: C29H30N6O5
  • Molecular Weight:542.59
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00